A director at New Mountain Finance Corp bought 237,873 shares at 8.100USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Day One Biopharmaceuticals, Inc. (DAWN - $12.87) and Jazz Pharmaceuticals PLC (JAZZ - $188.69)Shares Jump on News Speculation of Potential Acquisition.Yesterday, DAWN shares jumped as much as +30% after a Betaville "Uncooked Alert" was published stating that the company could be acquired by JAZZ. R
Angi Launches the Angi App in ChatGPT New app guides homeowners from question to contractors — moving from conversational AI recommendations in ChatGPT to matching with skilled pros on Angi DENVER, March 04, 2026 (GLOBE NEWSWIRE) -- As homeowners increasingly turn to AI to start home projects, (formerly Angie’s List) (NASDAQ: ANGI), a leading digital home services marketplace, today announced the launch of the Angi app in ChatGPT. This app enables homeowners to move from asking a home-improvement question in ChatGPT to connecting directly with a skilled pro on Angi. Angi is among the f...
A director at FTAI Aviation Ltd sold 10,000 shares at 303.350USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
We are updating our model for SBAC (Neutral, PT $212) following its 4Q25 results that were generally behind on most metrics. As we mentioned in our initial take, the company’s 2026 guidance doesn’t show much to get excited about, however, we are interested to see the progression of its dispute with SATS. The company stated that it filed its lawsuit against SATS on 2/25/26 and removed the revenue from its guide in line with the balance of the industry. Separating itself from others in the industr...
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th. Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative. About OPKO Health OPKO is a multinational biopharmaceutic...
SBAC (Neutral, PT $212) reported 4Q25 results that were below our estimates and consensus. The company stated that it filed its lawsuit against SATS on 2/25/26 and removed the revenue from its guide in line with the industry. 2026 guidance came in light vs. the street, which we think is in part due to messiness around SATS. The company mentioned that it won’t likely rise to its long-term growth targets until 2028 as it continues to work through churn events in 2026 and 2027. This note is our ins...
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial guidance for the first quarter and full year 2026. Highlights from the fourth quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. This n...
Carriage Services Announces Strong Fourth Quarter and Full Year 2025 Results and Issues 2026 Guidance Conference call on Thursday, February 26, 2026 at 8:00 a.m. Central Time HOUSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced its financial results for the fourth quarter and year ended December 31, 2025. Company Fourth Quarter and Full Year Highlights: GAAP diluted EPS of $0.77 compared to $0.62 in the prior year quarter, resulting in an increase of 24.2%;Adjusted diluted EPS of $0.75 compared to $0.62 in the prior year quarter, resulting in ...
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results BOSTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter and fiscal year ended December 31, 2025. Recent Highlights: Fourth quarter 2025 revenue from Continuing Operations of $23.8 million; Full Year 2025 revenue of $85.3 millionFully operationalized over $40 million in previously announced annualized cost savings supporting path to positive adjusted EBITDA and adjusted cash flow exiting 2026Ap...
A director at Patrick Industries Inc sold 2,660 shares at 141.030USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.